Cell Therapy in wound healing

Phase 1

Recruiting

• Conditions: diabetes mellitus type 1.; Type 1 diabetes mellitus with ulcer; E10.621

• Registration Number: IRCT20191007045008N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Signature of informed consent
Grade 1 or 2 wound on the Wagner Scale
With diagnosis of diabetic or other chronic wound
Female or male patient aged 15-45
Not pregnant

Exclusion Criteria

Patients with a history of uncontrolled disease
Pregnancy
Subjects with cancerous or pre-cancerous lesions in the area to be treated
Patient with working activity who cannot be on sick-leave during the study period
Known immunosuppressive disease, e.g. HIV infection, or hepatitis B or C infection

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
lcer Healing Rate. Timepoint: 7-14-21. Method of measurement: Ulcer Surface Area Measurement Using Instant Full-Scale Photography and analysis using Image J.

Secondary Outcome Measures

Name	Time	Method
Time to ulcer healing. Timepoint: 7-14-21. Method of measurement: Instant full scale photography and analysis using Image J.